_page-00019.jpg)
_page-00018.jpg)
_page-00011.jpg)
Email this article HIGH MATRIX METALLOPROTEINASE 9 EXPRESSION AS A RISK FACTOR OF LYMPHOVASCULAR INVASION IN CERVICAL CARCINOMA
Abstract
Background: Cervical carcinoma is an epithelial cancer with the highest mortality among female genital malignancies. Its poor prognosis is largely related to metastasis, which begins early through lymphovascular space invasion (LVSI). LVSI occurs when cancer cells invade surrounding tissue via proteolytic enzymes, but early prediction remains difficult. Although several molecular markers have been studied, none is definitive, and the role of matrix metalloproteinase-9 (MMP-9) in LVSI remains controversial.
Objective: This study will prove MMP-9 as a risk factor for LVSI in cervical carcinoma
Methods: This case–control study analyzed 40 archived paraffin-embedded tissue blocks from cervical carcinoma patients at BaliMed Denpasar Hospital. Immunohistochemical staining was performed to assess MMP-9 expression, while hematoxylin and eosin (H&E) staining was used to evaluate lymphovascular space invasion (LVSI). Statistical analysis was conducted using the chi-square test in SPSS version 25.
Results: The study showed that 85,7% of cervical carcinomas with LVSI have high MMP-9 expression, with a significant result compared to cervical cancer without LVSI (p=0.001, OR= 13.5).
Conclusions: The MMP-9 expression was significantly associated with the risk of LVSI in cervical carcinoma
Full Text:
PDFReferences
Widianti, B., Ariawan, I., Mela Dewi, LK., Nurhanita., Nugroho, AC., Apriyantoni, R. 2024. Rencana Kanker Nasional 2024-2034. Jakarta: Kementrian Kesehatan RI.
Daniyal M, Akhtar N, Ahmad S, Fatima U, Akram M, Asif HM. 2015. Update knowledge on cervical cancer incidence and prevalence in Asia. Asian Pac J Cancer Prev ;16(9):3617-20. doi: 10.7314/apjcp.2015.16.9.3617. PMID: 25987011.
Liu, Y., Li, L., Li, Y., Zhao, X. 2020. Research Progress on Tumor Associated Macrophages and Inflammation in Cervical Cancer. BioMed Research International, 2020, 6842963. https://doi.org/10.1155/2020/6842963
Georgescu, S.R. 2018. New Insights in the Pathogenesis of HPV Infection and the Associated Carcinogenic Processes: The Role of Chronic Inflammation and Oxidative Stress. Journal of Immunology Research 2018, pp. 1–10. Available at: http://dx.doi.org/10.1155/2018/5315816.
Endo, D., Todo, Y., Okamoto, K., Minobe, S., Kato, H., Nishiyama, N. 2015. “Prognosis factors for patients with cervical cancer treated with concurrent chemoradio theraphy: a retrospective in a Japanese cohort”. J Gyneco lOncol. 26 (1):12-18.
Haie-Meder, C., Morice, P., Castiglione. 2020. “Carvical cancer: ESMO clinical practice guidlines for diagnosis, tratment and follow up”. Ann Oncol.21: 37-40.
Herrington, C.S. Kim, K.R., Kong, C.S., Longacre, T.A., McCluggage, W.G. Mikami, Y.,Ordi, J,. Soslow, R.A., 2020. Tumorus of Uterine Cervix in World Health Organization, Female Genital Tumours. 5th edition; .pp 341-359
Huang, B., Cai, J., Xu, X., Guo,S.,Wang, Z. 2016. “High grade tumor budding stratifies earlystage cervical cancer with recurrence risk”. PLoS One.11(11): e0166311.
Kurman, R.J., Ronnett, B.M., Sherman, M.E., Wilkinson, E.J. 2015. “Tumous of the servix, vagina and vulva”. Thirdseries, Fasicle four. American Registry of Pathology in collaboration with the Armed Forces Institute of Pathology Washington, DC.p.431
Kumar, V., Abbas, A.K., Aster, J.C. 2015. Neoplasma. In: Robins and Cotrand: Pathologic Basis of Disease9thEd.Elsevier. Philladelphia.p.266-377.
Wang, A., Xu, Q., Sha, R, et al. 2020. “MicroRNA-29a inhibits cell Proliferation and Arrest Cell Cycle by Modulating p16 Methylation in Cervical Cancer”. Oncology Letters. Vol 21:1-9
Matsuo, K., Mandelbaum, R.S., Machida, H., Purushotham, S., Grubbs, B.H., Roman, L.D., Wright, J.D. 2018. Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix. Journal of Gynecologic Oncology, 29(6):e91. https://doi.org/10.3802/jgo.2018.29.e91.
Kuguyo, O., Tsikai, N., Thomford, N.E., Magwali, T., Madziyire, M.G., Nhachi, C.F.B., Matimba, A., Dandara, C. 2018. Genetic Susceptibility for Cervical Cancer in African Populations: What Are the Host Genetic Drivers? Omics: A Journal of Integrative Biology, 22(7):468–83. Available at: http://dx.doi.org /10.1089/omi.2018.0075.
Li, X., Yin, Y., Shen, X., Han, X., Sun, L., Lu, C., Wang, X. 2015. “Distribution pattern of lymphnode metastases and it simplication in individualized radiotherapeutic clinical target volume delineation of regional lymphnodes in patients with stage IA to IIA cervical cancer. Radiation Oncology”. Available from:https://rojournal.biomedcentral.com/articles/10.1186/s13014-015-0352-5
Sun, T.,Qin,Y.,Zhong,W.L.2016. “Epithelial-mesenchymal transition and its regulation in tumor metastasis. In: Tumor Metastasis”. Available from: http://www.intechopen.com/books/tumor-metastasis.
World Health Organization. 2018. “Comprehensive Cervical Cancer Control, 2nd edition, A Guideto Essential Practice”. Availlable from:https://www.ncbi.nlm.nih.gov/books/NBK269619/.
Jesinghaus, M., Strehl, J., Boxberg, M., dkk. 2018. Introducing a novel highly prognostic grading scheme based on tumor budding and cell nest size for squamous cell carcinoma of the uterine cervix. J Pathol Clin Res. 4: 93–102.
Matsuzaki, S., Klar, M., Mikami, M., Shimada, M., Grubbs, B. H., Fujiwara, K., Roman, L. D., Matsuo, K. 2020. Management of Stage IIB Cervical Cancer: an Overview of the Current Evidence. Current Oncology Reports, 22(3):28. Available at: http://dx.doi.org/10.1007/s11912-020-0888-x.
Sriwidyani, N., Alit-artha, I.G., Mantik-Astawa, I.N., Tjakra-Wibawa, I.B. 2016. “Tumor budding in breast carcinoma: relation to E-Cadherin, MMP-9 expression, and metastasis risk”. Bali Medical Journal (Bali Med J) 2016, Volume 5, Number 3: 497-501
Oktaviani, B.D., Sriwidyani, N.P., Sumadi, I.W.J. 2018. “Karakteristik Klinikopatologi Penderita Kanker Serviks Uteri Berdasarkan Data Di Laboratorium Patologi Anatomi RSUP Sanglah Denpasar Tahun 2011-2015”. E-Jurnal Medika Udayana. 7(8):1-6. Tersedia di: https://ojs.unud.ac.id/index.php/eum/article/view/41629. Akses: 05 Januari 2022.
Armerinayanti, N. W., Bakta, I. M., Alit Artha, I. G., Wahyuniari, I. A. I., & Widodo, S. 2023. “Overexpression of MicroRNA 21 in Cervical Carcinoma with Lymph Node Metastasis”. Biomedical and Pharmacology Journal, 16(1), 479–485. https://doi.org/10.13005/bpj/2628
Zare, S. Y., Aisagbonhi, O., Hasteh, F., & Fadare, O. 2020. Independent Validation of Tumor Budding Activity and Cell Nest Size as Determinants of Patient Outcome in Squamous Cell Carcinoma of the Uterine Cervix. The American journal of surgical pathology, 44(9), 1151–1160. https://doi.org/10.1097/PAS.0000000000001472
Zhang C, Liu K, Li T, Fang J, Ding Y, Sun L. 2016. miR-21: a gene of dual regulation in breast cancer. Int J Oncol. 2016;48:161-72.
Zhang, N., Wang, D., Duan, Y., Ayarick, V. A., Cao, M., Wang, Y., Zhang, G., & Wang, Y. (2020). The special immune microenvironment of tumor budding and its impact on prognosis in gastric adenocarcinoma. Pathology, research and practice, 216(6), 152926. https://doi.org/10.1016/j.prp.2020.152926.
Zlobec, I. & Lugli, A. 2018. Tumour budding in colorectal cancer: molecular rationale for clinical translation. Nat. Rev. Cancer 18, 203–2
Lestari, D. P. O., Wellere, A. I., Brill, I. K., Sari, N. L. P. E. K., Jolly, P. E., & Piyathilake, C. J. 2024. The Impact of an Educational Program on Cervical Cancer Knowledge Among HIV-Positive Women in Bali, Indonesia. International Journal of Women’s Health, 16(October), 1677–1685. https://doi.org/10.2147/IJWH.S480216
DOI: https://doi.org/10.33992/meditory.v13i2.4204
Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Ni Wayan Armerinayanti
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.